Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Sales | 2,319 | 0 | 0 |
| Gross Profit | 2,319 | N/A | N/A |
| Operating Expenses | 64,760 | 0 | 0 |
| Operating Income | -62,441 | N/A | N/A |
| Other Income | 562 | 0 | 0 |
| Pre-tax Income | -61,879 | 0 | 0 |
| Net Income Continuous | -61,879 | N/A | N/A |
| Net Income | $-61,879 | $N/A | $N/A |
| EPS Basic Total Ops | -2.87 | N/A | N/A |
| EPS Basic Continuous Ops | -2.87 | N/A | N/A |
| EPS Diluted Total Ops | -2.87 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.87 | N/A | N/A |
| EBITDA(a) | $-59,952 | $N/A | $N/A |